Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

News

News and Press Releases:

Photo of a group of people consisting of the scientists Dr. Christian Brandstetter and Prof. Till Strowig as well as the scientist Dr. Lisa Osbelt-Block in the middle.
© HZI/Janne Reinking
DZIF scientist Prof. Dr. Dr. med. Susanne Herold
© JLU/Rolf K. Wegst

Susanne Herold admitted to the German National Academy of Sciences Leopoldina

Prof. Dr. Dr. med. Susanne Herold, a renowned lung and infection researcher at Justus Liebig University Giessen (JLU) and the University Hospital of Giessen and Marburg and scientist at the German
A close-up image of a healthcare professional wearing white gloves administering a vaccine injection into a person's upper arm using a syringe.
© Mufid Majnun auf Unsplash

Therapeutic vaccine for chronic hepatitis B enters first clinical trial in patients

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich in collaboration with the German Center for Infection Research (DZIF), has entered its
Microscopic image of a diverse community of gut bacteria in various shapes and artificially colored hues on a dark background.
© Maier Lab (Lisa Maier, Anne Grießhammer, Leonardo Boldt), Tübingen Structural Microscopy Core Facility (Michaela Wilsch-Bräuninger, Stefan Fischer); Kolorierung/Coloring: Elke Neudert

Unexpected side effect: How common medications pave the way for pathogens

The human gut is home to a dense network of microorganisms, collectively known as the gut microbiome, which actively contributes to health. These microorganisms aid digestion, train the immune system
View of the world map with red markings indicating the latitudes and regions for which analyses of the dynamics of SARS-CoV-2 lines are available. SARS-CoV-2 viruses are symbolically distributed across the world map.
© CoVerage; CDC/Alissa Eckert, Dan Higgins

Data-driven detection of concerning SARS-CoV-2 variants months in advance

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants

DZIF Prize for Translational Infection Research 2025

Apply now!

The DZIF Prize for Translational Infection Research honors special scientific contributions in the field of translational research. The prize is endowed with 5,000 euros. Applications can be submitted to the DZIF Academy until October 6, 2025.

DZIF Prize for Translational Infection Research 2025
© hunthomas/Adobe Stock

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
3 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Research in Focus

Our Partner Sites

Research areas
Contact person

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover - Braunschweig
Project Manager Community-Acquired Infections at Mucosal Interfaces
Research areas
Contact person
Location

Bonn - Köln

Research areas
Contact person

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator Malaria and Neglected Tropical Diseases

Dr. Ullrich Bethe

University Hospital Cologne
Project Manager Clinical Trial Office (CTO)
Interim Partner Site Manager Cologne
Location

Heidelberg

Research areas
Contact person

Prof. Dr. Stephan Urban

Heidelberg University
Deputy Coordinator Hepatitis
DZIF Professor "Translational Virology"
Partner Site Speaker Heidelberg
15
Databases- & Biobanks 2023